Alpha DNA Investment Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,258
Closed -$463K 136
2024
Q4
$463K Buy
+10,258
New +$463K 0.18% 124